Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry

OBJECTIVE: The aim of the study was to estimate the radiation-absorbed doses and to study the in vivo and in vitro stability as well as pharmacokinetic characteristics of lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA)-617. METHODS: For this purpose, 7 patients who underwent Lu-177-P...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Imaging Radionucl Ther
Autores principales: Kabasakal, Levent, Toklu, Türkay, Yeyin, Nami, Demirci, Emre, Abuqbeitah, Mohammad, Ocak, Meltem, Aygün, Aslan, Karayel, Emre, Pehlivanoğlu, Hüseyin, Alan Selçuk, Nalan
Formato: Artigo
Lenguaje:Inglês
Publicado: Galenos Publishing 2017
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5472088/
https://ncbi.nlm.nih.gov/pubmed/28613198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/mirt.08760
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares